These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32410506)

  • 1. Baseline quality of life is associated with survival among people with advanced lung cancer.
    Trejo MJ; Bell ML; Dhillon HM; Vardy JL
    J Psychosoc Oncol; 2020; 38(5):635-641. PubMed ID: 32410506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 study.
    Hui R; Özgüroğlu M; Villegas A; Daniel D; Vicente D; Murakami S; Yokoi T; Chiappori A; Lee KH; de Wit M; Cho BC; Gray JE; Rydén A; Viviers L; Poole L; Zhang Y; Dennis PA; Antonia SJ
    Lancet Oncol; 2019 Dec; 20(12):1670-1680. PubMed ID: 31601496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Brain Metastasis on Patient-Reported Outcomes in Advanced NSCLC Treated in Real-World Community Oncology Settings.
    Walker MS; Wong W; Ravelo A; Miller PJE; Schwartzberg LS
    Clin Lung Cancer; 2018 Mar; 19(2):139-147. PubMed ID: 29103883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-Reported Outcome Measures Used in Routine Care Predict for Survival at Disease Progression in Patients With Advanced Lung Cancer.
    Friis RB; Hjøllund NH; Pappot H; Taarnhøj GA; Vestergaard JM; Skuladottir H
    Clin Lung Cancer; 2021 Mar; 22(2):e169-e179. PubMed ID: 33160899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.
    Garassino MC; Gadgeel S; Esteban E; Felip E; Speranza G; Domine M; Hochmair MJ; Powell S; Cheng SY; Bischoff HG; Peled N; Reck M; Hui R; Garon EB; Boyer M; Wei Z; Burke T; Pietanza MC; Rodríguez-Abreu D
    Lancet Oncol; 2020 Mar; 21(3):387-397. PubMed ID: 32035514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial.
    Brahmer JR; Rodríguez-Abreu D; Robinson AG; Hui R; Csőszi T; Fülöp A; Gottfried M; Peled N; Tafreshi A; Cuffe S; O'Brien M; Rao S; Hotta K; Zhang J; Lubiniecki GM; Deitz AC; Rangwala R; Reck M
    Lancet Oncol; 2017 Dec; 18(12):1600-1609. PubMed ID: 29129441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptom and Quality of Life Improvement in LUX-Lung 8, an Open-Label Phase III Study of Second-Line Afatinib Versus Erlotinib in Patients With Advanced Squamous Cell Carcinoma of the Lung After First-Line Platinum-Based Chemotherapy.
    Felip E; Hirsh V; Popat S; Cobo M; Fülöp A; Dayen C; Trigo JM; Gregg R; Waller CF; Soria JC; Goss GD; Gordon J; Wang B; Palmer M; Ehrnrooth E; Gadgeel SM
    Clin Lung Cancer; 2018 Jan; 19(1):74-83.e11. PubMed ID: 28729180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health Outcomes for Definite Concurrent Chemoradiation in Locally Advanced Non-Small Cell Lung Cancer: A Prospective Study.
    Nguyen PAH; Vercauter P; Verbeke L; Beelen R; Dooms C; Tournoy KG
    Respiration; 2019; 97(4):310-318. PubMed ID: 30466111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life with cemiplimab plus chemotherapy for first-line treatment of advanced non-small cell lung cancer: Patient-reported outcomes from phase 3 EMPOWER-Lung 3.
    Makharadze T; Quek RGW; Melkadze T; Gogishvili M; Ivanescu C; Giorgadze D; Dvorkin M; Penkov K; Laktionov K; Nemsadze G; Nechaeva M; Rozhkova I; Kalinka E; Gessner C; Moreno-Jaime B; Passalacqua R; Konidaris G; Rietschel P; Gullo G
    Cancer; 2023 Jul; 129(14):2256-2265. PubMed ID: 37151113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The utility of abbreviated patient-reported outcomes for predicting survival in early stage colorectal cancer.
    Hsu T; Speers CH; Kennecke HF; Cheung WY
    Cancer; 2017 May; 123(10):1839-1847. PubMed ID: 28081292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: a national phase III trial.
    Sundstrøm S; Bremnes R; Aasebø U; Aamdal S; Hatlevoll R; Brunsvig P; Johannessen DC; Klepp O; Fayers PM; Kaasa S
    J Clin Oncol; 2004 Mar; 22(5):801-10. PubMed ID: 14990635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life as a clinical trial endpoint: determining the appropriate interval for repeated assessments in patients with advanced lung cancer.
    Hollen PJ; Gralla RJ; Rittenberg CN
    Support Care Cancer; 2004 Nov; 12(11):767-73. PubMed ID: 15206013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-reported outcomes with first-line durvalumab plus platinum-etoposide versus platinum-etoposide in extensive-stage small-cell lung cancer (CASPIAN): a randomized, controlled, open-label, phase III study.
    Goldman JW; Garassino MC; Chen Y; Özgüroğlu M; Dvorkin M; Trukhin D; Statsenko G; Hotta K; Ji JH; Hochmair MJ; Voitko O; Havel L; Poltoratskiy A; Losonczy G; Reinmuth N; Patel N; Laud PJ; Shire N; Jiang H; Paz-Ares L
    Lung Cancer; 2020 Nov; 149():46-52. PubMed ID: 32961445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of change in symptoms, respiratory status, nutritional profile and quality of life on response to treatment for advanced non-small cell lung cancer.
    Mohan A; Singh P; Kumar S; Mohan C; Pathak AK; Pandey RM; Guleria R
    Asian Pac J Cancer Prev; 2008; 9(4):557-62. PubMed ID: 19256738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness outcomes and health related quality of life impact of disease progression in patients with advanced nonsquamous NSCLC treated in real-world community oncology settings: results from a prospective medical record registry study.
    Walker MS; Wong W; Ravelo A; Miller PJE; Schwartzberg LS
    Health Qual Life Outcomes; 2017 Aug; 15(1):160. PubMed ID: 28806963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of Baseline Edmonton Symptom Assessment Scale Scores on Treatment and Survival in Patients With Advanced Non-small-cell Lung Cancer.
    McGee SF; Zhang T; Jonker H; Laurie SA; Goss G; Nicholas G; Albaimani K; Wheatley-Price P
    Clin Lung Cancer; 2018 Jan; 19(1):e91-e99. PubMed ID: 28666762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Impact of erlotinib treatment on symptoms and quality of life in patients with advanced non-small-cell lung cancer].
    Zhou SW; Ren SX; Yan LH; Zhang L; Zhou CC
    Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):469-72. PubMed ID: 19024526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Early Palliative Care Use With Survival and Place of Death Among Patients With Advanced Lung Cancer Receiving Care in the Veterans Health Administration.
    Sullivan DR; Chan B; Lapidus JA; Ganzini L; Hansen L; Carney PA; Fromme EK; Marino M; Golden SE; Vranas KC; Slatore CG
    JAMA Oncol; 2019 Dec; 5(12):1702-1709. PubMed ID: 31536133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of immunotherapy for survivors of stage IV non-small cell lung cancer: patient perspectives on quality of life.
    Park R; Shaw JW; Korn A; McAuliffe J
    J Cancer Surviv; 2020 Jun; 14(3):363-376. PubMed ID: 31950409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-Reported Outcomes From Patients Receiving Immunotherapy or Chemoimmunotherapy for Metastatic Non-Small-Cell Lung Cancer in Clinical Practice.
    Steffen McLouth LE; Lycan TW; Levine BJ; Gabbard J; Ruiz J; Farris M; Grant SC; Pajewski NM; Weaver KE; Petty WJ
    Clin Lung Cancer; 2020 May; 21(3):255-263.e4. PubMed ID: 31917067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.